1. Home
  2. NERV vs TG Comparison

NERV vs TG Comparison

Compare NERV & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

N/A

Current Price

$4.43

Market Cap

231.1M

Sector

Health Care

ML Signal

N/A

Logo Tredegar Corporation

TG

Tredegar Corporation

N/A

Current Price

$7.76

Market Cap

262.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NERV
TG
Founded
2007
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
231.1M
262.4M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
NERV
TG
Price
$4.43
$7.76
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.50
N/A
AVG Volume (30 Days)
132.9K
165.9K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
151.06
EPS
N/A
0.34
Revenue
$41,175,600.00
$800,821,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$22.44
Revenue Growth
N/A
8.29
52 Week Low
$1.93
$6.25
52 Week High
$12.46
$10.53

Technical Indicators

Market Signals
Indicator
NERV
TG
Relative Strength Index (RSI) 49.84 44.22
Support Level $3.87 $7.57
Resistance Level $4.73 $8.12
Average True Range (ATR) 0.33 0.24
MACD -0.03 -0.04
Stochastic Oscillator 19.49 21.44

Price Performance

Historical Comparison
NERV
TG

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

Share on Social Networks: